RHT (RHT) Fair Value & Analysis
Healthcare · Market cap A$19.1M
Fair value as of: Jun 26, 2026
From 9 valuation models · updated 6 days ago
Fair value updated Jun 26, 2026 — revised from A$0.0200 to A$0.0340 (+70.2%) since Jun 25, 2026. Share price +9.8% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.0337 – A$0.0562 · fair‑value band A$0.0294 – A$0.0386 · the A$0.0460 price screens above the A$0.0340 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
RHT (RHT) currently trades at A$0.0460, while our model-based Fair Value estimate is A$0.0340 — implying the stock looks roughly 26.0% overvalued today. We read business quality at 51/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, RHT generated revenue of A$13.8M at a net margin of 5.6%. Revenue grew 53.1% year over year. It earns a return on equity of 7.3%. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
RHT reported revenue of A$11.1M in FY2025 versus A$3.8M in FY2021, a compound +30.8%/yr. Reported net income was −A$1.7M in FY2025.
Is RHT fairly valued? → Check now
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $163.76 | $103.58 | -37% |
| Pro Medicus Limited PME | A$172.80 | A$32.25 | -81% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $84.61 | $79.57 | -6% |
| M3, Inc MTHRY | $5.03 | $7.44 | +48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is RHT (RHT) undervalued?
What is the fair value of RHT?
What is the quality score of RHT?
What is the revenue of RHT (RHT)?
What is the net profit margin of RHT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.